Previous Article | Next Article ![]()
Molecular and Cellular Biology, January 1999, p. 317-320, Vol. 19, No. 1
Departments of
Pharmacology1 and
Biochemistry2 and the
Howard
Hughes Medical Institute,3 University of
Washington, Seattle, Washington 98195
Received 16 March 1998/Returned for modification 3 May
1998/Accepted 7 October 1998
p90rsk is a distal member of the
mitogen-activated protein kinase signaling pathway. It has been cloned
from a variety of species including Xenopus laevis, mouse,
chicken, rat, and human. The clone p90rsk-mo-1,
isolated by others from a mouse library, contains a unique
33-nucleotide deletion not found in the p90rsk
clones from any other species that have been examined. When
p90rsk-mo-1 was expressed in Cos-7 cells that
were subsequently stimulated with epidermal growth factor, the
immunoprecipitated p90rsk-mo-1 protein showed
no measurable kinase activity toward the ribosomal protein S6 peptide.
By comparison, expression of rat p90rsk-1
resulted in significant kinase activity. Deletion of the
33-nucleotide region missing in the p90rsk-mo-1
clone from the p90rsk-rat-1 cDNA abolished
kinase activity in the resulting protein. When these 33 nucleotides
were introduced into the p90rsk-mo-1 cDNA, the
expressed protein showed significant kinase activity. Reverse
transcription-PCR and direct sequencing of mRNA isolated from several
mouse tissues indicated the presence of the full-length form of
p90rsk-1 in the mouse and showed no conclusive
evidence for a deletion-containing form. This study indicates the
presence of a full-length p90rsk-1 mRNA in
mouse tissues that is homologous to that identified in other species
and suggests that the deletion in p90rsk-mo-1
may be a cloning artifact. The findings provide additional support for
the conclusion that the first catalytic domain of
p90rsk is responsible for its enzymatic
activity toward ribosomal protein S6.
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Deletion of 11 Amino Acids in p90rsk-mo-1
Abolishes Kinase Activity
and
*
Corresponding author. Mailing address: Department of
Pharmacology, University of Washington, 1595 N.E. Pacific St., Box
357370, Seattle, WA 98195. Phone: (206) 543-8500. Fax: (206) 543-0858. E-mail: egkrebs{at}u.washington.edu.
Present address: Department of Surgery, University of Washington,
Seattle, WA 98195.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|